5XJV image
Deposition Date 2017-05-04
Release Date 2018-04-11
Last Version Date 2023-11-22
Entry Detail
PDB ID:
5XJV
Keywords:
Title:
Two intermediate states of conformation switch in dual specificity phosphatase 13a
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.69 Å
R-Value Free:
0.22
R-Value Work:
0.17
R-Value Observed:
0.18
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Dual specificity protein phosphatase 13 isoform A
Gene (Uniprot):DUSP13A
Mutations:C18A, C35A, C77A, C129S, C176A
Chain IDs:A, B
Chain Length:185
Number of Molecules:2
Biological Source:Homo sapiens
Ligand Molecules
Primary Citation
Two intermediate states of the conformational switch in dual specificity phosphatase 13a
Pharmacol. Res. 128 211 219 (2018)
PMID: 29106959 DOI: 10.1016/j.phrs.2017.10.006

Abstact

Dual specificity phosphatases (DUSPs) include MAP kinase phosphatases and atypical dual specificity phosphatases and mediate cell growth and differentiation, brain function, and immune responses. They serve as targets for drug development against cancers, diabetes and depression. Several DUSPs have non-canonical conformation of the central β-sheet and active site loops, suggesting that they may have conformational switch that is related to the regulation of enzyme activity. Here, we determined the crystal structure of DUSP13a, and identified two different structures that represent intermediates of the postulated conformational switch. Amino acid sequence of DUSP13a is not significantly homologous to DUSPs with conformational switch, indicating that the conformational switch is not sequence-dependent, but rather determined by ligand interaction. The sequence-independency suggests that other DUSPs with canonical conformation may have the conformational switch during specific cellular regulation. The conformational switch leads to significant changes in the protein surface, including a hydrophobic surface and pockets, which can be exploited for development of allosteric modulators of drug target DUSPs.

Legend

Protein

Chemical

Disease

Primary Citation of related structures